UNIGE document Scientific Article
previous document  unige:18863  next document
add to browser collection

Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials

Decuypere, Saskia
Alexandrenne, Coralie
De Doncker, Simonne
Boelaert, Marleen
Dujardin, Jean-Claude
show hidden authors show all authors [1 - 13]
Published in Infection and immunity. 2009, vol. 77, no. 5, p. 2022-9
Abstract The mechanisms linking the immune response to cutaneous and mucosal leishmaniasis (CL and ML, respectively) lesions and the response to treatment are incompletely understood. Our aims were to prospectively assess, by quantitative reverse transcription-PCR, the levels of mRNA for gamma interferon, tumor necrosis factor alpha, interleukin-10 (IL-10), IL-4, and IL-13, as well as the presence of T cells (CD2) and macrophages (CD68), in CL and ML lesions and to follow their changes in response to treatment with pentavalent antimonials. The leishmanin skin test (LST) was performed on all CL and ML patients before treatment. The patient population included individuals living in areas of Peru where the disease is endemic, i.e., 129 with CL and 43 with ML. Compared to CL patients, the LST induration size was larger, the levels of all cytokine mRNAs but IL-10 were higher, T-cell mRNA was similar, and macrophage mRNA was lower in ML patients. The proportion of CL patients with an LST induration size of >8 mm was higher among responders to treatment. In CL, the pretreatment levels of cytokine mRNAs did not discriminate between responders and nonresponders; however, treatment was more often accompanied by a reduction in the levels of T-cell and cytokine mRNAs in responders than in nonresponders. Furthermore, the production of cytokines per T cell and macrophage decreased with treatment but IL-10 production remained high in nonresponders. Overall, these findings point to complex relationships among New World Leishmania parasites, skin and mucosal immune responses, and treatment outcome. The persistence of high levels of IL-10 in CL is characteristically associated with a poor response to treatment.
Keywords AdolescentAdultAgedAged, 80 and overAnimalsAntimony/therapeutic useAntiprotozoal Agents/therapeutic useChildChild, PreschoolCytokines/biosynthesisFemaleGene Expression ProfilingHumansInfantLeishmaniasis, Cutaneous/drug therapy/immunologyMacrophages/immunologyMaleMiddle AgedPeruProspective StudiesSkin/pathologyT-Lymphocytes/immunologyTreatment OutcomeYoung Adult
PMID: 19237520
Full text
Article (Published version) (666 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://iai.asm.org/content/77/5/2022.full.pdf
Research groups Groupe Jean-Michel Gaspoz (23)
Groupe Louis Loutan (médecine des Voyages et des Migrations, Médecine Tropicale, Santé Internationale) (122)
La matrice extracellulaire (651)
(ISO format)
MAURER-CECCHINI, Anne et al. Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. In: Infection and immunity, 2009, vol. 77, n° 5, p. 2022-9. doi: 10.1128/IAI.01513-08 https://archive-ouverte.unige.ch/unige:18863

515 hits

0 download


Deposited on : 2012-03-19

Export document
Format :
Citation style :